Cargando…
Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks
While aspirin may offer protection, other non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) can cause serious cardiovascular side effects and complications. This has led to a general "black box" warning for cardiovascular adverse events for NSAIDs. This review explores the differe...
Autores principales: | Meek, Inger L., van de Laar, Mart A.F.J., Vonkeman, Harald E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036661/ https://www.ncbi.nlm.nih.gov/pubmed/27713346 http://dx.doi.org/10.3390/ph3072146 |
Ejemplares similares
-
Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort
por: Meek, Inger L, et al.
Publicado: (2014) -
Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature
por: Meek, Inger L, et al.
Publicado: (2014) -
Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study
por: Vonkeman, Harald E, et al.
Publicado: (2007) -
Incremental cost effectiveness of proton pump inhibitors for the prevention of non-steroidal anti-inflammatory drug ulcers: a pharmacoeconomic analysis linked to a case-control study
por: Vonkeman, Harald E, et al.
Publicado: (2008) -
Risk management of risk management: Combining proton pump inhibitors with low-dose aspirin
por: Vonkeman, Harald, et al.
Publicado: (2010)